Pregnant Women's Knowledge of the Active and Passive Smoking Effects on Pregnancy and the Fetus
NCT ID: NCT06117943
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2023-12-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Indeed, many pregnant women are still over-exposed to tobacco, either through personal use or passive exposure to cigarette smoke. This passive exposure often comes from the consumption of their loved ones, such as their future co-parent or family.
However, throughout our lives, health professionals, associations, and the government send a lot of information and messages about the negative effects of tobacco on health, pregnancy, and the fetus.
This information and the possibility of receiving help from a professional trained in tobacco use exist throughout the entire pregnancy.
However, many women and their partners still do not take the necessary precautions to reduce or stop smoking. Do couples who smoke during pregnancy really have an understanding of the smoking's effects on women and their fetuses? Could they realize it and would they reduce or stop their consumption, in case they knew these negative effects?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women
NCT03842449
Maternal Smoking Exposure and Newborn Outcomes: Study Using Urinary Cotinine
NCT07201181
Obstetric Complications in Women Who Smoke During Pregnancy
NCT01758276
Monoamine Oxidases in Smoking Pregnant Women and Newborns
NCT00169390
Examining a New Biomarker of Nicotine Use Among Pregnant Women Who Participated in the New England SCRIPT
NCT00519766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To describe the knowledge of pregnant women who smoke or are exposed to tobacco smoke about the effects of active and passive smoking on the obstetrical and fetal systems.
* To identify the information that has been received by pregnant women who smoke or are confronted with tobacco smoke about the effects of tobacco on pregnancy.
* To identify information sources for pregnant women who smoke or are exposed to tobacco smoke about the negative effects of tobacco on pregnancy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women
Pregnant women who smoke personally or are passively exposed to cigarette smoke
data collection
Pregnant women who smoke personally or are passively exposed to cigarette smoke
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
data collection
Pregnant women who smoke personally or are passively exposed to cigarette smoke
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primigravida women
* women exposed to passive or active smoking
* women aged over 18 years
* Accepting to participate in the study
Exclusion Criteria
* protected by law (guardianship, custodianship, judicial protection)
* refusing to participate in the study
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ufr Medecine Urca
Reims, , France
Université de Reims Champagne Ardenne
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023_RIPH_013_tabac-GO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.